With the recent identification of several new fusion genes that have refined molecular classification and risk stratification in B-ALL (19, 20), a comprehensive evaluation of the relationship between EVI1 expression patterns, molecular subtypes, and prognostic significance remains a significant unmet need. The gene discussed is MECOM; the disease is acute lymphoblastic leukemia.